These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9147441)

  • 1. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 3. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract]   [Full Text] [Related]  

  • 6. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
    AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis.
    Moyle G; Gazzard BG
    Am J Med; 1995 Mar; 98(3):319-20. PubMed ID: 7872356
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.
    Balfour HH
    Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
    Jacobson MA
    Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of the management of cytomegalovirus retinitis in patients with AIDS].
    López-Cortés LF; Pachón-Díaz J
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):137-41. PubMed ID: 8695680
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
    Desatnik HR; Foster RE; Lowder CY
    Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
    Dodds EM; Lowder CY; Foster RE; Avery RK; Prayson RA
    Arch Ophthalmol; 1996 Jul; 114(7):896-7. PubMed ID: 8660181
    [No Abstract]   [Full Text] [Related]  

  • 16. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
    Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G
    AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphonoformate for CMV retinitis in AIDS.
    Colucciello M
    Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.